alagebrium has been researched along with Heart Failure in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartog, JW; Hummel, YM; Posma, JL; van Veldhuisen, DJ; van Wijk, LM; Voors, AA; Willemsen, S | 1 |
| Hartog, JW; Hillege, HL; Hummel, YM; Posma, JL; van Veldhuisen, DJ; van Wijk, LM; Voors, AA; Willemsen, S | 1 |
| Bakris, GL; Bank, AJ; Kass, DA; Neutel, JM; Oparil, S; Preston, RA | 1 |
| Degroof, RC; Hundley, WG; Kitzman, DW; Little, WC; O'Brien, TX; Zile, MR | 1 |
| Redfield, MM | 1 |
| Doggrell, SA | 1 |
3 review(s) available for alagebrium and Heart Failure
| Article | Year |
|---|---|
Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
Topics: Aging; Animals; Blood Pressure; Blood Vessels; Cardiovascular Agents; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Glycation End Products, Advanced; Heart Failure; Humans; Hypertension; Thiazoles | 2004 |
Treating diastolic heart failure with AGE crosslink breakers: thinking outside the heart failure box.
Topics: Animals; Clinical Trials as Topic; Collagen; Drug Evaluation, Preclinical; Glycation End Products, Advanced; Heart Failure; Humans; Thiazoles; Ventricular Dysfunction, Left | 2005 |
ALT-711 decreases cardiovascular stiffness and has potential in diabetes, hypertension and heart failure.
Topics: Animals; Diabetes Mellitus; Heart Failure; Humans; Hypertension; Thiazoles | 2001 |
3 trial(s) available for alagebrium and Heart Failure
| Article | Year |
|---|---|
Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial.
Topics: Diastole; Double-Blind Method; Echocardiography, Stress; Exercise Test; Exercise Tolerance; Female; Glycation End Products, Advanced; Health Status Indicators; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Research Design; Stroke Volume; Surveys and Questionnaires; Systole; Thiazoles; Ventricular Function, Left | 2010 |
Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.
Topics: Aged; Cardiovascular Agents; Chronic Disease; Diagnostic Techniques, Cardiovascular; Double-Blind Method; Exercise Tolerance; Female; Glycation End Products, Advanced; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Thiazoles | 2011 |
The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.
Topics: Aged; Aorta; Blood Flow Velocity; Blood Pressure; Echocardiography; Exercise Test; Female; Glycation End Products, Advanced; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Oxygen Consumption; Prospective Studies; Quality of Life; Surveys and Questionnaires; Thiazoles; Ventricular Dysfunction, Left | 2005 |